meddevicedb.com FDA Device Reference

URIC ACID ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM

K022096 Class I Traditional
Decision Date
2003-03-18
Sponsor / Applicant
Bayer Diagnostics Corp.

Technical Specification

510(k) Submission ID K022096
Product Code KNK
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1775
Decision Date 2003-03-18
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

URIC ACID ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM received FDA 510(k) clearance under submission number K022096, sponsored by Bayer Diagnostics Corp.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2003-03-18.

Classification & Regulation

This clearance is catalogued under FDA product code KNK and 21 CFR 862.1775, within the Clinical Chemistry review panel as a Class I device.